Effect of omalizumab on FeNO in patients with severe bronchial asthma

Effect of omalizumab on FeNO in patients with severe bronchial asthma - Effect of omalizumab on FeNO

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000002146

Enrollment

Registered

2009-07-01

Start date

2009-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe persistent brochial asthma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with severe allergic asthma whose symptoms are not controlled well by high-dose inhaled glucocorticosteroids and other anti-asthmatic agents.

Exclusion criteria

Exclusion criteria: Pregnat women and patients whose weight is less than 30kg.

Design outcomes

Primary

Measure	Time frame
FeNO	—

Secondary

Measure	Time frame
Score of asthma control test	—

Countries

Japan

Contacts

Public ContactTamotsu Ishizuka

Gunma University Graduate School of Medicine Department of Medicine and Molecular Science

027-220-8123

Outcome results